Targeting the Activin Type IIB Receptor to Improve Muscle Mass and Function in the mdx Mouse Model of Duchenne Muscular DystrophyEmidio E. Pistilli(University of Pennsylvania), Tejvir S. Khurana(University of Pennsylvania)American Journal Of PathologyFebruary 27, 201110.1016/j.ajpath.2010.11.071Cited by 107SaveCiteExport RISWatch citationsRelated PapersSkeletal muscle reprogramming by breast cancer regardless of treatment history or tumor molecular subtype|npj Breast Cancer|2020|31Functional improvement of dystrophic muscle by repression of utrophin: let-7c interaction|PLoS ONE|2017|25